Evaluation of a Novel Boron-Containing α-<span style="font-variant: small-caps">d</span>-Mannopyranoside for BNCT

Boron neutron capture therapy (BNCT) is a unique anticancer technology that has demonstrated its efficacy in numerous phase I/II clinical trials with boronophenylalanine (BPA) and sodium borocaptate (BSH) used as ¹⁰B delivery agents. However, continuous drug administration at high concent...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Takao Tsurubuchi, Makoto Shirakawa, Wataru Kurosawa, Kayo Matsumoto, Risa Ubagai, Hiroshi Umishio, Yasuyo Suga, Junko Yamazaki, Akihiro Arakawa, Yutaka Maruyama, Takuya Seki, Yusuke Shibui, Fumiyo Yoshida, Alexander Zaboronok, Minoru Suzuki, Yoshinori Sakurai, Hiroki Tanaka, Kei Nakai, Eiichi Ishikawa, Akira Matsumura
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2020-05-01
Serija:	Cells
Teme:	boron-containing α-<span style="font-variant: small-caps">d</span>-mannopyranoside closo-dodecarborate low-molecular-weight compound BNCT
Online dostop:	https://www.mdpi.com/2073-4409/9/5/1277
Oznake:	Označite Brez oznak, prvi označite!